《LANCET,3月31日,SARS-CoV-2: a time for clear and immediate action》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-04-02
  • SARS-CoV-2: a time for clear and immediate action

    Gregory A Poland

    Published:March 31, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30250-4

    I have spent a 33-year career studying respiratory RNA viruses, devising vaccine approaches against them, and unravelling the human immune response to these viruses and vaccines, as well as promoting policies to minimise their effects. Over the past 10 weeks, I and many others have been in the thick of explaining what we know about coronaviruses and other respiratory viruses, and extrapolating this knowledge to understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to many health-care providers, organisations, media, and lay people.

  • 原文来源:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30250-4/fulltext#
相关报告
  • 《LANCET,3月3日,Has China faced only a herald wave of SARS-CoV-2?》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-04
    • The attack rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) calculated by math-ematical models, from estimates of the basic reproduction number, R0, of 2–3, suggests that 50–60% of the population should eventually be infected because the population seems to be entirely naive to the new virus.The observed attack rate on board the Diamond Princess cruise ship remained slightly below 20% (705 of 3711 passengers and crew members became infected).
  • 《LANCET,3月23日,SARS-CoV-2: virus dynamics and host response》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-24
    • SARS-CoV-2: virus dynamics and host response Yu Chen Lanjuan Li Published:March 23, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30235-8 Since December, 2019, coronavirus disease 2019 (COVID-19) has affected more than 100?000 patients globally.1 COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has a case-fatality rate of 2·3%, with higher rates among elderly patients and patients with comorbidities.2 Person-to-person transmission is efficient, with multiple clusters reported. Clinically, patients with COVID-19 present with respiratory symptoms, which is very similar to the presentation of other respiratory virus infections.